Drug Type Antibody fusion proteins |
Synonyms |
Target |
Mechanism IgA protease inhibitors(IgA protease inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glomerulonephritis, IGA | Preclinical | US | 01 May 2022 | |
Glomerulonephritis, IGA | Preclinical | CN | 01 May 2022 |